Macleods Pharmaceuticals Limited — Levofloxacin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Levofloxacin · $11.0M export value · DGFT Verified
Macleods Pharmaceuticals Limited is the #9 Indian exporter of Levofloxacin with $11.0M in export value and 62 verified shipments. Macleods Pharmaceuticals Limited holds a 13.2% market share in Levofloxacin exports across 19 countries. The company exports 64 pharmaceutical products worth $589.8M across 20 therapeutic categories.
Macleods Pharmaceuticals Limited — Levofloxacin Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Limited Export Levofloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KAZAKISTAN | $812.4K | 20 | 14.2% |
| UZBEKISTAN | $698.8K | 27 | 12.2% |
| NETHERLANDS | $527.0K | 24 | 9.2% |
| SOUTH AFRICA | $523.8K | 28 | 9.1% |
| UNITED STATES | $498.2K | 30 | 8.7% |
| PHILIPPINES | $438.4K | 17 | 7.6% |
| POLAND | $412.4K | 20 | 7.2% |
| KAZAKHSTAN | $350.0K | 7 | 6.1% |
| MOZAMBIQUE | $157.7K | 10 | 2.7% |
| LEBANON | $144.8K | 14 | 2.5% |
Macleods Pharmaceuticals Limited exports Levofloxacin to 43 countries. The largest destination is KAZAKISTAN accounting for 14.2% of Macleods Pharmaceuticals Limited's Levofloxacin shipments, followed by UZBEKISTAN (12.2%) and NETHERLANDS (9.2%). These destinations reflect Macleods Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Levofloxacin from Macleods Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FE ADVANCE PHARMACEUTICAL BUSINESS | UZBEKISTAN | $698.8K | 27 |
| BRANCH COMPANY MACLEODS PHARMACEUTI | KAZAKISTAN | $612.4K | 16 |
| MACLEODS PHARMACEUTICALS SA (PTY) | SOUTH AFRICA | $511.3K | 24 |
| BRANCH COMPANY MACLEODS | KAZAKHSTAN | $500.0K | 10 |
| DEPARTMENT OF HEALTH -(PHILIPPINES) | PHILIPPINES | $301.4K | 13 |
| IDA FOUNDATION | NETHERLANDS | $241.6K | 15 |
| MACLEODS PHARMA USA.INC | UNITED STATES | $187.9K | 14 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $167.8K | 9 |
| IDA FOUNDATION DB SCHENKAR LOGISTICS | NETHERLANDS | $150.0K | 3 |
| MACLEODS PHARMACEUTICALS LIMITED LL | POLAND | $150.0K | 3 |
Macleods Pharmaceuticals Limited supplies Levofloxacin to 70 buyers globally. The largest buyer is FE ADVANCE PHARMACEUTICAL BUSINESS (UZBEKISTAN), followed by BRANCH COMPANY MACLEODS PHARMACEUTI (KAZAKISTAN) and MACLEODS PHARMACEUTICALS SA (PTY) (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Levofloxacin Export Value and How Much Does Macleods Pharmaceuticals Limited Contribute?
India exported $36.0M worth of Levofloxacin through 6,304 shipments from 699 suppliers to 150 countries, serving 1,543 buyers globally. Macleods Pharmaceuticals Limited contributes $11.0M to this total, accounting for 13.2% of India's Levofloxacin exports. Macleods Pharmaceuticals Limited ships Levofloxacin to 43 countries through 70 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Limited's Levofloxacin Exports?
Macleods Pharmaceuticals Limited's average Levofloxacin shipment value is $177.9K per consignment, based on 62 shipments totaling $11.0M. The largest destination is KAZAKISTAN (14.2% of Macleods Pharmaceuticals Limited's Levofloxacin exports).
How Does Macleods Pharmaceuticals Limited Compare to Other Indian Levofloxacin Exporters?
Macleods Pharmaceuticals Limited ranks #9 among 699 Indian Levofloxacin exporters with a 13.2% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($9.5M), MICRO LABS LIMITED ($5.0M), SENTISS PHARMA PRIVATE LIMITED ($4.7M). Macleods Pharmaceuticals Limited processed 62 shipments to 19 destination countries.
What Levofloxacin Formulations Does Macleods Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LEVOFLOXACIN 500MG TABLETS, NET CONT: LE | $416.4K | 16 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML ) | $300.0K | 6 |
| MEDICINES. LEVOFLOXACIN 500MG TABLETS(Ne | $234.4K | 7 |
| LEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/100ML) 1X100ML | $216.7K | 5 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOFLOXACIN 250 MG TABLETS | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOMAC 500(LEVOFLOXACIN 500MG TABLETS) | $150.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOMAC IV (LEVOFLOXACIN INFUSION 500 MG/100 ML) | $148.6K | 4 |
| LEVOMAC IV (LEVOFLOXACIN INFUSION 500MG/100ML) 1X100 MLNOS | $137.0K | 3 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOFLOXACIN TABLETS 500 MGNOS | $109.5K | 6 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOFLOXACIN TABLETS 500 MG | $103.1K | 6 |
Macleods Pharmaceuticals Limited exports 187 distinct Levofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LEVOFLOXACIN 500MG TABLETS, NET CONT: LE with 16 shipments worth $416.4K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Macleods Pharmaceuticals Limited Compare to Nearest Levofloxacin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | ZYDUS LIFESCIENCES LIMITED | $2.5M | 97 | 8 | $25.9K |
| 8 | DR.REDDY'S LABORATORIES LTD | $2.2M | 53 | 4 | $41.0K |
| 9 | MACLEODS PHARMACEUTICALS LIMITED ★ | $1.5M | 62 | 19 | $24.3K |
| 11 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $1.3M | 27 | 4 | $48.4K |
| 5 | MEDCELL PHARMA | $1.3M | 26 | 5 | $50.0K |
Macleods Pharmaceuticals Limited ranks #9 among 699 Indian Levofloxacin exporters. Average shipment value of $24.3K compared to the market average of $51.5K. The closest competitors by value are ZYDUS LIFESCIENCES LIMITED and DR.REDDY'S LABORATORIES LTD.
Which Indian Ports Ship Levofloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 670 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 633 | 10.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 620 | 9.8% |
| DELHI AIR | 531 | 8.4% |
| NHAVA SHEVA SEA (INNSA1) | 439 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 240 | 3.8% |
| JNPT | 186 | 3.0% |
| Bombay Air | 164 | 2.6% |
What Other Antibiotics Products Does Macleods Pharmaceuticals Limited Export?
Macleods Pharmaceuticals Limited also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Macleods Pharmaceuticals Limited's Levofloxacin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Macleods Pharmaceuticals. The Israel-Iran tensions have escalated security risks in the Red Sea and Strait of Hormuz, leading to increased shipping costs and extended transit times. Major carriers have rerouted vessels around the Cape of Good Hope, adding 10–20 days to shipments and raising freight rates by 40–50% on key India–Europe routes. (livemint.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. However, potential U.S. tariffs on Indian pharmaceutical imports pose a significant risk. A 25% tariff could render many low-margin generic drugs unprofitable, compelling companies to scale back operations or exit certain product segments, thereby exacerbating drug shortages in the U.S. (cfo.economictimes.indiatimes.com)
The recent India–European Union Free Trade Agreement, signed in January 2026, offers a favorable development by eliminating tariffs on most pharmaceutical products. This agreement is expected to enhance the competitiveness of Indian exporters in the EU market, providing a counterbalance to challenges in other regions. (en.wikipedia.org)
Macleods Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a cornerstone for Indian pharmaceutical exporters. Macleods Pharmaceuticals' recent recalls in the U.S. market, including the Famciclovir tablet recall due to contamination, highlight the critical need for stringent adherence to Good Manufacturing Practices (GMP). Such incidents can tarnish a company's reputation and impede market access. (pharma.economictimes.indiatimes.com)
The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates robust serialization and traceability measures. Indian exporters must invest in advanced compliance systems to meet these requirements, ensuring product integrity and sustaining export growth.
About Macleods Pharmaceuticals Limited
Macleods Pharmaceuticals Limited exports 64 products worth $589.8M. Beyond Levofloxacin, top products include Isoniazid, Rifampicin, Tenofovir, Valsartan, Artemether. View the complete Macleods Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levofloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 318 individual customs records matching Macleods Pharmaceuticals Limited exporting Levofloxacin, covering 187 formulations to 43 countries via 70 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,543+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levofloxacin Export Data from Macleods Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Limited's Levofloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Limited
Full Company Profile →
64 products · $589.8M total trade · 20 categories
Levofloxacin Stats
Company Overview
Top Products by Macleods Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levofloxacin. For current shipment-level data, contact TransData Nexus.